Nivolumab and Bevacizumab for recurrent Glioblastoma; a translational trial in progress

Simone Eibye; Benedikte Hasselbalch; Inge Marie Svane; Sine Reker Hadrup; Lars Rønn Olsen; Jane Skjoeth-Rasmussen; David Scheie; Olga Ostrup; Hans Skovgaard Poulsen; Ulrik Lassen

doi:10.1093/neuonc/noz175.001

Nivolumab and Bevacizumab for recurrent Glioblastoma; a translational trial in progress

Simone Eibye
, Benedikte Hasselbalch
, Inge Marie Svane
, Sine Reker Hadrup
, Lars Rønn Olsen
, Jane Skjoeth-Rasmussen
, David Scheie
, Olga Ostrup
, Hans Skovgaard Poulsen
, Ulrik Lassen

Copenhagen University Hospital Herlev and Gentofte
Rigshospitalet

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	Neuro-Oncology
Volume	21
Issue number	Supplement_6
Number of pages	1
ISSN	1522-8517
DOIs	https://doi.org/10.1093/neuonc/noz175.001
Publication status	Published - 2019

Access to Document

10.1093/neuonc/noz175.001

OpenUrl availability

Check availability in DTU Findit

Cite this

@article{66db6fd31b0a4880a88e4b7c56c4da46,

title = "Nivolumab and Bevacizumab for recurrent Glioblastoma; a translational trial in progress",

author = "Simone Eibye and Benedikte Hasselbalch and Svane, \{Inge Marie\} and Hadrup, \{Sine Reker\} and Olsen, \{Lars R{\o}nn\} and Jane Skjoeth-Rasmussen and David Scheie and Olga Ostrup and Poulsen, \{Hans Skovgaard\} and Ulrik Lassen",

year = "2019",

doi = "10.1093/neuonc/noz175.001",

language = "English",

volume = "21",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "Supplement\_6",

}

TY - ABST

T1 - Nivolumab and Bevacizumab for recurrent Glioblastoma; a translational trial in progress

AU - Eibye, Simone

AU - Hasselbalch, Benedikte

AU - Svane, Inge Marie

AU - Hadrup, Sine Reker

AU - Olsen, Lars Rønn

AU - Skjoeth-Rasmussen, Jane

AU - Scheie, David

AU - Ostrup, Olga

AU - Poulsen, Hans Skovgaard

AU - Lassen, Ulrik

PY - 2019

Y1 - 2019

U2 - 10.1093/neuonc/noz175.001

DO - 10.1093/neuonc/noz175.001

M3 - Conference abstract in journal

SN - 1522-8517

VL - 21

JO - Neuro-Oncology

JF - Neuro-Oncology

IS - Supplement_6

ER -